Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) EBITDA Margin (2025)

BioAge Labs (BIOA) has disclosed EBITDA Margin for 1 consecutive years, with 842.76% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin changed N/A to 842.76% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 895.74% through Dec 2025, changed N/A year-over-year, with the annual reading at 895.74% for FY2025, N/A changed from the prior year.
  • EBITDA Margin hit 842.76% in Q4 2025 for BioAge Labs, up from 978.97% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 842.76% in Q4 2025 to a low of 978.97% in Q3 2025.